Home » Topics » Regulatory » Patents

Patents
RSS

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

No Comments

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

No Comments

Bayer develops CETP inhibitors

Dec. 4, 1997

No Comments

Diagnostic use of specific sigma2 ligands described by Wake Forest University

Dec. 4, 1997

No Comments

MDR modulators prepared at Janssen

Dec. 4, 1997

No Comments

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

No Comments

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

No Comments

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

No Comments

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

No Comments

CoCensys/Acea reveal new AMPA receptor antagonists/positive modulators

Dec. 3, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Patents
RSS

DuPont Merck develops novel CRF antagonists

Vitronectin receptor antagonists described by Hoechst

Bayer develops CETP inhibitors

Diagnostic use of specific sigma2 ligands described by Wake Forest University

MDR modulators prepared at Janssen

Antiviral thiazolidines and thiazolidinones from INSERM

Neurogen patents new dopamine receptor subtype-specific ligands

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Compounds for 5-HT-mediated disorders from Astra

CoCensys/Acea reveal new AMPA receptor antagonists/positive modulators

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Patents RSS

Patents
RSS